Loading data for BBH — first visit, this takes a few seconds.

VanEck Biotech ETF

BBH · NasdaqGM · USD

229.39 +0.68 (0.30%)

收盘价： Sep 11, 2026, 8:00 PM

229.26 -0.06%

盘后: 7:30 PM

管理资产规模（AUM）469.37M

费用率0.35%

平均成交量（20日）7,841

持仓无

基金概览

前十大持仓

查看更多持仓 ↗

名称	代码	权重
	AMGN	15.66%
	GILD	12.68%
	VRTX	8.54%
	REGN	6.80%
	MRNA	5.70%
	NTRA	5.08%
	RVMD	5.03%
	IQV	5.02%
	ARGX	4.72%
	ILMN	3.34%

主要行业

Healthcare100.00%

关于BBH

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

分红

完整分红历史 ↗

股息收益率: 0.42%
金额: 0.957
除息日: 2025-12-22
支付日期: 无

交易数据

买价: 210.43
市值: 无
贝塔（Beta）: 0.62
每股收益（EPS，过去十二个月）: 无
市盈率（PE，过去十二个月）: 24.58
流通股数: 无
卖价: 210.68
成交量: 2,743
开盘价: 229.47
前收盘价: 228.71
日内区间: 229.39 - 230.31
52周区间: 160.91 - 244.35

股价变动原因

新闻

3周前 · Zacks

Bet on These Biotech ETFs as Innovation Drives Market-Beating Growth

Biotech ETFs are riding a powerful rally fueled by innovation, obesity drugs and M&A, with three funds offering diversified exposure to growth.

3周前 · Zacks

Healthcare ETFs Are Looking Up: Here's Why

Healthcare ETFs are hitting 52-week highs as earnings improve, dealmaking accelerates, FDA approvals stay strong and investors seek defensive growth.

2月前 · Zacks

Should You Invest in the VanEck Biotech ETF (BBH)?

Sector ETF report for BBH

3月前 · Zacks

Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market

GLP-1 drugs are reshaping healthcare and consumer markets. These ETFs offer targeted exposure to the booming obesity-drug trend.

6月前 · Zacks

The Zacks Analyst Blog Highlights IBB, XBI, BBH and GNOM

IBB and peers are gaining traction as AI transforms biotech, boosting drug discovery, trials and growth prospects across diversified ETF portfolios.

第 1 页，共 2 页